For GLP-1 players looking to sustain market position and capture long-term value, strategic differentiation beyond pricing thus becomes essential
GLP-1 agonists activate receptors in the brain's appetite centres, reducing hunger and increasing satiety, whilst also slowing gastric emptying to prolong fullness after meals, collectively leading to reduced food intake and weight loss
As for people who should not use epitalon, we know that this group includes women who are pregnant or breastfeeding , as there isnt enough research to confirm the safety of the mother, their fetus, or their developing child
In pharmacology, an agonist is a substance that binds to a specific receptor on a cell and triggers a response, mimicking the action of a naturally occurring substance
How long does tirzepatide take to start working for weight loss